These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 11251014

  • 1. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
    Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Müller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Göbel U, Treuner J, Voûte PA, Zoubek A, Gadner H, Jürgens H.
    J Clin Oncol; 2001 Mar 15; 19(6):1818-29. PubMed ID: 11251014
    [Abstract] [Full Text] [Related]

  • 2. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M, Craft AW, Lewis I, Hackshaw A, Douglas C, Dunst J, Schuck A, Winkelmann W, Köhler G, Poremba C, Zoubek A, Ladenstein R, van den Berg H, Hunold A, Cassoni A, Spooner D, Grimer R, Whelan J, McTiernan A, Jürgens H, European Intergroup Cooperative Ewing's Sarcoma Study-92.
    J Clin Oncol; 2008 Sep 20; 26(27):4385-93. PubMed ID: 18802150
    [Abstract] [Full Text] [Related]

  • 3. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
    Dunst J, Jürgens H, Sauer R, Pape H, Paulussen M, Winkelmann W, Rübe C.
    Int J Radiat Oncol Biol Phys; 1995 Jul 15; 32(4):919-30. PubMed ID: 7607966
    [Abstract] [Full Text] [Related]

  • 4. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS, Torrey M, Link MP, Glicksman A, Gilula L, Laurie F, Manning J, Neff J, Reinus W, Thompson E, Shuster JJ.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):125-35. PubMed ID: 9747829
    [Abstract] [Full Text] [Related]

  • 5. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
    Ferrari S, Mercuri M, Rosito P, Mancini A, Barbieri E, Longhi A, Rimondini S, Cesari M, Ruggieri P, Di Liddo M, Bacci G.
    J Chemother; 1998 Dec 01; 10(6):484-91. PubMed ID: 9876058
    [Abstract] [Full Text] [Related]

  • 6. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Tural D, Molinas Mandel N, Dervisoglu S, Oner Dincbas F, Koca S, Colpan Oksuz D, Kantarci F, Turna H, Selcukbiricik F, Hiz M.
    Jpn J Clin Oncol; 2012 May 01; 42(5):420-6. PubMed ID: 22416252
    [Abstract] [Full Text] [Related]

  • 7. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J, Ahrens S, Paulussen M, Rübe C, Winkelmann W, Zoubek A, Harms D, Jürgens H.
    Int J Radiat Oncol Biol Phys; 1998 Sep 01; 42(2):379-84. PubMed ID: 9788419
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
    Ahrens S, Hoffmann C, Jabar S, Braun-Munzinger G, Paulussen M, Dunst J, Rübe C, Winkelmann W, Heinecke A, Göbel U, Winkler K, Harms D, Treuner J, Jürgens H.
    Med Pediatr Oncol; 1999 Mar 01; 32(3):186-95. PubMed ID: 10064186
    [Abstract] [Full Text] [Related]

  • 9. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
    Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, Bernstein M, Laurie F, Gebhardt MC, Grier HE, Tarbell NJ, Children's Oncology Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3838-43. PubMed ID: 16921035
    [Abstract] [Full Text] [Related]

  • 10. [Surgery versus radiotherapy in Ewing's sarcoma with good prognosis. Analysis of the CESS-86 data].
    Dunst J, Hoffmann C, Ahrens S, Jürgens H.
    Strahlenther Onkol; 1996 May 20; 172(5):244-8; discussion 249. PubMed ID: 8633255
    [Abstract] [Full Text] [Related]

  • 11. Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
    Schuck A, Hofmann J, Rübe C, Hillmann A, Ahrens S, Paulussen M, Jürgens H, Dunst J, Willich N.
    Int J Radiat Oncol Biol Phys; 1998 Dec 01; 42(5):1001-6. PubMed ID: 9869222
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
    Bacci G, Picci P, Ferrari S, Mercuri M, Brach del Prever A, Rosito P, Barbieri E, Tienghi A, Forni C.
    Cancer; 1998 Mar 15; 82(6):1174-83. PubMed ID: 9506366
    [Abstract] [Full Text] [Related]

  • 13. [The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years].
    Jürgens H, Bier V, Dunst J, Harms D, Jobke A, Kotz R, Kühl J, Müller-Weihrich S, Ritter J, Salzer-Kuntschik M.
    Klin Padiatr; 1988 Mar 15; 200(3):243-52. PubMed ID: 3145357
    [Abstract] [Full Text] [Related]

  • 14. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
    Bacci G, Picci P, Ruggieri P, Ferrari S, Mercuri M, Fabbri N, Rosito P, Barbieri E, Ferraro A, Casadei R.
    J Chemother; 1993 Aug 15; 5(4):247-57. PubMed ID: 8229153
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.
    Bacci G, Ferrari S, Bertoni F, Donati D, Bacchini P, Longhi A, Brach Del Prever A, Forni C, Rimondini S.
    J Clin Oncol; 2000 Feb 15; 18(4):885-92. PubMed ID: 10673532
    [Abstract] [Full Text] [Related]

  • 16. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
    Jürgens H, Exner U, Kühl J, Ritter J, Treuner J, Weinel P, Winkler K, Göbel U.
    Cancer Chemother Pharmacol; 1989 Feb 15; 24 Suppl 1():S40-4. PubMed ID: 2503258
    [Abstract] [Full Text] [Related]

  • 17. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.
    Craft A, Cotterill S, Malcolm A, Spooner D, Grimer R, Souhami R, Imeson J, Lewis I.
    J Clin Oncol; 1998 Nov 15; 16(11):3628-33. PubMed ID: 9817284
    [Abstract] [Full Text] [Related]

  • 18. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH, Meyers PA.
    J Clin Oncol; 2001 Feb 01; 19(3):870-80. PubMed ID: 11157041
    [Abstract] [Full Text] [Related]

  • 19. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
    Brunetto AL, Castillo LA, Petrilli AS, Macedo CD, Boldrini E, Costa C, Almeida MT, Kirst D, Rodriguez-Galindo C, Pereira WV, Watanabe FM, Pizza M, Benites E, Morais V, Gadelha A, Nakasato A, Abujamra AL, Gregianin LJ, Brazilian Collaborative On behalf of the Brazilian Collaborative Study Group of Ewing Family of Tumors EWING1 and the Brazilian Society of Pediatric Oncology SOBOPE.
    Pediatr Blood Cancer; 2015 Oct 01; 62(10):1747-53. PubMed ID: 25917418
    [Abstract] [Full Text] [Related]

  • 20. Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.
    Le Deley MC, Paulussen M, Lewis I, Brennan B, Ranft A, Whelan J, Le Teuff G, Michon J, Ladenstein R, Marec-Bérard P, van den Berg H, Hjorth L, Wheatley K, Judson I, Juergens H, Craft A, Oberlin O, Dirksen U.
    J Clin Oncol; 2014 Aug 10; 32(23):2440-8. PubMed ID: 24982464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.